Early Access — free while we kick the tires
EdgarHawk

Rubinstein Samuel

Director

Director
1 filing analyzed · 1 company · Latest 2025-11-18

Companies

Company Buys Sells Direction
STRATA Skin Sciences, Inc. SSKN 5 0 Net buying

Activity

November 2025
high
Buy
5,000 shares
$7,028
Significance 7/10

Director Rubinstein sells 14,094 shares (50.9% of holdings) over two days at $1.32–$1.36, then buys 5,000 shares at $1.40–$1.41

Rubinstein executed 3 separate sales totaling 14,094 shares for $18,803.84 on November 17, reducing his holdings by 50.9%, followed by purchases of 5,000 shares for $7,028.32 on November 18 at slightly higher prices. The timing of these paired transactions—large liquidation immediately followed by smaller acquisition—coincides with stock weakness; SSKN has declined 27.0% over 30 days and 58.8% from its 52-week high of $3.35. The company is unprofitable with net income of $-1,622,000.00 in the latest quarter and minimal growth (0.6% annual revenue growth). The net effect is a substantial reduction in Rubinstein's stake from 17,860 to 8,766 shares, suggesting a material shift in exposure to the company despite the modest reacquisition on the following day.

Related insiders

Create a free account

Build watchlists, get email alerts on the tickers you follow, and read the full AI analysis on every insider filing.

Sign up — free during early access